Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, May 24, 2022
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
Salveen Richter Maintained (BLUE) at Strong Sell with Decreased Target to $2 on, May 24th, 2022
Salveen Richter of Goldman Sachs, Maintained "bluebird bio, Inc." (BLUE) at Strong Sell with Decreased Target from $3 to $2 on, May 24th, 2022.
Salveen has made no other calls on BLUE in the last 4 months.
There are 5 other peers that have a rating on BLUE. Out of the 5 peers that are also analyzing BLUE, 3 agree with Salveen's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Mani Foroohar of "SVB Leerink" Maintained at Hold with Decreased Target to $8 on, Wednesday, April 6th, 2022
- Yaron Werber of "Cowen & Co." Downgraded from Buy to Hold on, Wednesday, April 6th, 2022
- Yanan Zhu of "Wells Fargo" Maintained at Hold with Decreased Target to $8 on, Tuesday, March 8th, 2022
These are the ratings of the 2 analyists that currently disagree with Salveen
- Matthew Harrison of "Morgan Stanley" Maintained at Sell with Decreased Target to $3 on, Tuesday, May 17th, 2022
- Gena Wang of "Barclays" Maintained at Sell with Decreased Target to $3 on, Tuesday, May 10th, 2022
